A Comprehensive Update on Late-Onset Pompe Disease
Biomolecules · 22.08.2023 · 13 (9) · 1279
DOI: 10.3390/biom13091279 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biomolecules, online erschienen am 22.08.2023. Verfasst von Beatrice Labella und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical and Experimental Sciences, University of Brescia, 25100 Brescia, Italy. Hauptthemen laut MEDLINE: Glycogen Storage Disease Type II. Die Arbeit wurde bisher 62-mal zitiert (Crossref) und nennt 217 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Pompe disease (PD) is an autosomal recessive disorder caused by mutations in the GAA gene that lead to a deficiency in the acid alpha-glucosidase enzyme. Two clinical presentations are usually considered, named infantile-onset Pompe disease (IOPD) and late-onset Pompe disease (LOPD), which differ in age of onset, organ involvement, and severity of disease. Assessment of acid alpha-glucosidase activity on a dried blood spot is the first-line screening test, which needs to be confirmed by genetic analysis in case of suspected deficiency. LOPD is a multi-system disease, thus requiring a multidisciplinary approach for efficacious management. Enzyme replacement therapy (ERT), which was introduced over 15 years ago, changes the natural progression of the disease. However, it has limitations, including a reduction in efficacy over time and heterogeneous therapeutic responses among patients. Novel therapeutic approaches, such as gene therapy, are currently under study. We provide a comprehensive review of diagnostic advances in LOPD and a critical discussion about the advantages and limitations of current and future treatments.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical and Experimental Sciences, University of Brescia, 25100 Brescia, Italy.
- Unit of Neurology, ASST Spedali Civili, 25100 Brescia, Italy.
- NeMO-Brescia Clinical Center for Neuromuscular Diseases, 25064 Brescia, Italy.
ORCID-Profile: Simona Damioli, Loris Poli, Massimiliano Filosto
Zitieren
APA
Labella, B., Cotti Piccinelli, S., Risi, B., Caria, F., Damioli, S., Bertella, E., Poli, L., Padovani, A., & Filosto, M. (2023). A Comprehensive Update on Late-Onset Pompe Disease. Biomolecules, 13(9), 1279. https://doi.org/10.3390/biom13091279
Vancouver
Labella B, Cotti Piccinelli S, Risi B, Caria F, Damioli S, Bertella E, et al. A Comprehensive Update on Late-Onset Pompe Disease. Biomolecules. 2023;13(9):1279. doi:10.3390/biom13091279
BibTeX
@article{Labella2023,
author = {Labella, Beatrice and Cotti Piccinelli, Stefano and Risi, Barbara and Caria, Filomena and Damioli, Simona and Bertella, Enrica and Poli, Loris and Padovani, Alessandro and Filosto, Massimiliano},
title = {A Comprehensive Update on Late-Onset Pompe Disease},
journal = {Biomolecules},
year = {2023},
volume = {13},
number = {9},
pages = {1279},
doi = {10.3390/biom13091279}
}
EUVIMED